Ellagic acid, a new antiglycating agent: Its inhibition of N ε-(carboxymethyl)lysine

Biochemical Journal

Volumn 442, Issue 1, 2012, Pages 221-230

  Muthenna, Puppala ^a   Akileshwari, Chandrasekhar ^a   Reddy, G Bhanuprakash ^a  

^a NATIONAL INSTITUTE OF NUTRITION   (India)

Author keywords

Advanced glycation end product (AGE); Ellagic acid; Haemoglobin (Hb); Lens protein; Lens transparency; Lysozyme; N (carboxymethyl)lysine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ASCORBIC ACID; BOVINE SERUM ALBUMIN; CARBONYL DERIVATIVE; ELLAGIC ACID; FRUCTOSE; GLYCOSYLATED HEMOGLOBIN; LYSINE DERIVATIVE; LYSOZYME; METHYLGLYOXAL; N EPSILON(CARBOXYMETHYL)LYSINE; PROTEIN; RIBOSE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIGLYCATING ACTIVITY; ARTICLE; BETA SHEET; CHELATION; CIRCULAR DICHROISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA OPACITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; EX VIVO STUDY; HUMAN; HUMAN TISSUE; LENS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RAT;

ANIMALS; CRYSTALLINS; DIABETES COMPLICATIONS; ELLAGIC ACID; GLUCONATES; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LACTONES; LENS, CRYSTALLINE; LYSINE; MALE; MURAMIDASE; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84856282540     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20110846     Document Type: Article

References (55)

1. Wild, S., Roglic, G., Green, A., Sicree, R. and King, H. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053 (Pubitemid 38579764)
2. Mohan, V., Sandeep, S., Deepa, R., Shah, B. and Varghese, C. (2007) Epidemiology of type 2 diabetes: Indian scenario. Indian J. Med. Res. 125, 217-230 (Pubitemid 46805444)
3. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820
4. Singh, R., Barden, A., Mori, T. and Beilin, L. (2001) Advanced glycation end-products: a review. Diabetologia 44, 129-146 (Pubitemid 32156196)
5. Baynes, J. W. and Thorpe, S. R. (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48, 1-9 (Pubitemid 29019345)
6. Ahmed, N. (2005) Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67, 3-21
7. Brownlee, M. (1995) Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46, 223-234
8. Nagaraj, R. H. and Sady, C. (1996) The presence of a glucose-derived Maillard reaction product in the human lens. FEBS Lett. 382, 234-238 (Pubitemid 26092198)
9. Vlassara, H. (1996) Advanced glycation end-products and atherosclerosis. Ann. Med. 28, 419-426
10. Sell, D. R. and Monnier, V. M. (1989) Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J. Biol. Chem. 264, 21597-21602 (Pubitemid 20028722)
11. Sell, D. R., Nagaraj, R. H., Grandhee, S. K., Odetti, P., Lapolla, A., Fogarty, J. and Monnier, V. M. (1991) Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. Diabetes Metab. Rev. 7, 239-251
12. Lyons, T. J., Silvestri, G., Dunn, J. A., Dyer, D. G. and Baynes, J. W. (1991) Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts. Diabetes 40, 1010-1015
13. Willemsen, S., Hartog, J. W., Heiner-Fokkema, M. R., van Veldhuisen, D. J. and Voors, A. A. (2011) Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome. Heart Fail. Rev. doi:10.1007/s10741-010- 9225-z
14. Harding, J. J. (1991) Post-translational modification of lens proteins in cataract. Lens Eye Toxic Res. 8, 245-250
15. Miyazawa, T., Nakagawa, K., Shimasaki, S. and Nagai, R., Lipid glycation and protein glycation in diabetes and atherosclerosis. (2010) Amino Acids doi:10.1007/s00726-010-0772-3
16. Luthra, M. and Balasubramanian, D. (1993) Nonenzymatic glycation alters protein structure and stability. A study of two eye lens crystallins. J. Biol. Chem. 268, 18119-18127 (Pubitemid 23260332)
17. Kumar, M. S., Reddy, P. Y., Kumar, P. A., Surolia, I. and Reddy, G. B. (2004) Effect of dicarbonyl-induced browning on alpha-crystallin chaperone-like activity: physiological significance and caveats of in vitro aggregation assays. Biochem. J. 379, 273-282 (Pubitemid 38570099)
18. Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D. and Stern, D. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269, 9889-9897 (Pubitemid 24196599)
19. Kumar, P. A., Kumar, M. S. and Reddy, G. B. (2007) Effect of glycation on alpha-crystallin structure and chaperone-like function. Biochem. J. 408, 251-258 (Pubitemid 350206348)
20. Shuvaev, V. V., Laffont, I., Serot, J. M., Fujii, J., Taniguchi, N. and Siest, G. (2001) Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol. Aging 22, 397-402 (Pubitemid 32510910)
21. Dyer, D. G., Dunn, J. A., Thorpe, S. R., Bailie, K. E., Lyons, T. J., McCance, D. R. and Baynes, J. W. (1993) Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest. 91, 2463-2469 (Pubitemid 23182497)
22. Vlassara, H. (1996) Advanced glycosylation in nephropathy of diabetes and aging. Adv. Nephrol. Necker. Hosp. 25, 303-315
23. Stitt, A., Gardiner, T. A., Alderson, N. L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A. S., Chachich, M., Baynes, J. W. and Thorpe, S. R. (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51, 2826-2832 (Pubitemid 34970937)
24. Vasan, S., Zhang, X., Kapurniotu, A., Bernhagen, J., Teichberg, S., Basgen, J., Wagle, D., Shih, D., Terlecky, I., Bucala, R. et al. (1996) An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 382, 275-278 (Pubitemid 26251366)
25. Rahbar, S. and Figarola, J. L. (2003) Novel inhibitors of advanced glycation endproducts. Arch. Biochem. Biophys. 419, 63-79 (Pubitemid 37287559)
26. Freedman, B. I., Wuerth, J. P., Cartwright, K., Bain, R. P., Dippe, S., Hershon, K., Mooradian, A. D. and Spinowitz, B. S. (1999) Design and baseline characteristics for the Aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). Control Clin. Trials 20, 493-510 (Pubitemid 29460926)
27. Taguchi, T., Sugiura, M., Hamada, Y. and Miwa, I. (1998) In vivo formation of a Schiff base of aminoguanidine with pyridoxal phosphate. Biochem. Pharmacol. 55, 1667-1671 (Pubitemid 28223459)
28. Thornalley, P. J. (2003) Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys. 419, 31-40
29. Jurenka, J. S. (2008) Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern. Med. Rev. 13, 128-144
30. Corbett, S., Daniel, J., Drayton, R., Field, M., Steinhardt, R. and Garrett, N. Evaluation of the anti-inflammatory effects of ellagic acid. (2010) J. Perianesth. Nurs. 25, 214-220
31. Heber, D. (2008) Multitargeted therapy of cancer by ellagitannins. Cancer Lett. 269, 262-268
32. Lee, W. J., Ou, H. C., Hsu, W. C., Chou, M. M., Tseng, J. J., Hsu, S. L., Tsai, K. L. and Sheu, W. H. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J. Vasc. Surg. 52, 1290-1300
33. Saraswat, M., Reddy, P. Y., Muthenna, P. and Reddy, G. B. (2009) Prevention of non-enzymic glycation of proteins by dietary agents: prospects for alleviating diabetic complications. Br. J. Nutr. 101, 1714-1721
34. Mrudula, T., Suryanarayana, P., Srinivas, P. N. and Reddy, G. B. (2007) Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina. Biochem. Biophys. Res. Commun. 361, 528-532 (Pubitemid 47187290)
35. Kumar, P. A., Reddy, P. Y., Srinivas, P. N. and Reddy, G. B. (2009) Delay of diabetic cataract in rats by the antiglycating potential of cumin through modulation of alpha-crystallin chaperone activity. J. Nutr. Biochem. 20, 553-562
36. Saraswat, M., Suryanarayana, P., Reddy, P. Y., Patil, M. A., Balakrishna, N. and Reddy, G. B. (2010) Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats. Mol. Vis. 16, 1525-1537
37. De Ancos, B., Gonzalez, E. M. and Cano, M. P. (2000) Ellagic acid, vitamin C, and total phenolic contents and radical scavenging capacity affected by freezing and frozen storage in raspberry fruit. J. Agric. Food Chem. 48, 4565-4570
38. Landete, J. M. (2011) Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food Res. Int. 44, 1150-1160
39. Sen, S., Kar, M., Roy, A. and Chakraborti, A. S. (2005) Effect of nonenzymatic glycation on functional and structural properties of hemoglobin. Biophys. Chem. 113, 289-298 (Pubitemid 40037809)
40. Ahmad, M. S., Pischetsrieder, M. and Ahmed, N. (2007) Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts. Eur. J. Pharmacol. 561, 32-38 (Pubitemid 46435858)
41. Kiho, T., Usui, S., Hirano, K., Aizawa, K. and Inakuma, T. (2004) Tomato paste fraction inhibiting the formation of advanced glycation end-products. Biosci. Biotechnol. Biochem. 68, 200-205 (Pubitemid 39251584)
42. Price, D. L., Rhett, P. M., Thorpe, S. R. and Baynes, J. W. (2001) Chelating activity of advanced glycation end-product inhibitors. J. Biol. Chem. 276, 48967-48972
43. Booth, A. A., Khalifah, R. G., Todd, P. and Hudson, B. G. (1997) In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways. J. Biol. Chem. 272, 5430-5437 (Pubitemid 27102361)
44. Rahbar, S. and Nadler, J. L. (1999) A new rapid method to detect inhibition of Amadori product generated by delta-gluconolactone. Clin. Chim. Acta 287, 123-130 (Pubitemid 29413014)
45. Muthenna, P., Akileshwari, C., Saraswat, M. and Bhanuprakash Reddy, G. (2011) Inhibition of advanced glycation end-product formation on eye lens protein by rutin. Br. J. Nutr. 25, 1-9
46. Lee, W. J., Ou, H. C., Hsu, W. C., Chou, M. M., Tseng, J. J., Hsu, S. L., Tsai, K. L. and Sheu, W. H. (2010) Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J. Vasc. Surg. 52, 1290-1300
47. King, H., Aubert, R. E. and Herman, W. H. (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21, 1414-1431 (Pubitemid 28405191)
48. Wada, R., Nishizawa, Y., Yagihashi, N., Takeuchi, M., Ishikawa, Y., Yasumura, K., Nakano, M. and Yagihashi, S. (2001) Effects of OPB-9195, anti-glycation agent, on experimental diabetic neuropathy. Eur. J. Clin. Invest. 31, 513-520 (Pubitemid 32579388)
49. Booth, A. A., Khalifah, R. G. and Hudson, B. G. (1996) Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine. Biochem. Biophys. Res. Commun. 220, 113-119
50. Kusirisin, W., Srichairatanakool, S., Lerttrakarnnon, P., Lailerd, N., Suttajit, M., Jaikang, C. and Chaiyasut, C. (2009) Antioxidative activity, polyphenolic content and antiglycation effect of some Thai medicinal plants traditionally used in diabetic patients. Med. Chem. 5, 139-147
51. Nakagawa, T., Yokozawa, T., Terasawa, K., Shu, S. and Juneja, L. R. (2002) Protective activity of green tea against free radical- and glucose-mediated protein damage. J. Agric. Food Chem. 50, 2418-2422 (Pubitemid 34275319)
52. Tasaki, M., Umemura, T., Maeda, M., Ishii, Y., Okamura, T., Inoue, T., Kuroiwa, Y., Hirose, M. and Nishikawa, A. (2008) Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats. Food Chem. Toxicol. 46, 1119-1124
53. Ihnat, M. A., Thorpe, J. E. and Ceriello, A. (2007) Hypothesis: the 'metabolic memory', the new challenge of diabetes. Diabet. Med. 24, 582-586 (Pubitemid 46808866)
54. Srivastava, S. K., Ramana, K. V. and Bhatnagar, A. (2005) Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr. Rev. 26, 380-392 (Pubitemid 40691299)
55. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275